Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes

Nature

Volumn 463, Issue 7279, 2010, Pages 360-363

  Dalgliesh, Gillian L ^a   Furge, Kyle ^b   Greenman, Chris ^a   Chen, Lina ^a   Bignell, Graham ^a   Butler, Adam ^a   Davies, Helen ^a   Edkins, Sarah ^a   Hardy, Claire ^a   Latimer, Calli ^a   Teague, Jon ^a   Andrews, Jenny ^a   Barthorpe, Syd ^a   Beare, Dave ^a   Buck, Gemma ^a   Campbell, Peter J ^a   Forbes, Simon ^a   Jia, Mingming ^a   Jones, David ^a   Knott, Henry ^a   Kok, Chai Yin ^a   Lau, King Wai ^a   Leroy, Catherine ^a   Lin, Meng Lay ^a   McBride, David J ^a   Maddison, Mark ^a   Maguire, Simon ^a   McLay, Kirsten ^a   Menzies, Andrew ^a   Mironenko, Tatiana ^a   Mulderrig, Lee ^a   Mudie, Laura ^a   Ogmeara, Sarah ^a   Pleasance, Erin ^a   Rajasingham, Arjunan ^a   Shepherd, Rebecca ^a   Smith, Raffaella ^a   Stebbings, Lucy ^a   Stephens, Philip ^a   Tang, Gurpreet ^a   Tarpey, Patrick S ^a   Turrell, Kelly ^a   Dykema, Karl J ^b   Khoo, Sok Kean ^c   Petillo, David ^c   Wondergem, Bill ^b   Anema, John ^d   Kahnoski, Richard J ^d   Teh, Bin Tean ^c,e   Stratton, Michael R ^a,f   Futreal, P Andrew ^a   more..

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b Laboratory of Computational Biology   (Belgium)

^c VAN ANDEL RESEARCH INSTITUTE   (United States)

^d SPECTRUM HEALTH   (United States)

^e DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^f INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H3; JARID1C PROTEIN; SETD2 PROTEIN; UNCLASSIFIED DRUG; UTX PROTEIN;

CANCER; CARCINOGEN; GENE; MUTATION; PROTEIN; TAXONOMY;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CHROMATIN; CLEAR CELL CARCINOMA; DNA MODIFICATION; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC HETEROGENEITY; GENETIC IDENTIFICATION; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN MODIFICATION; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GENE;

CARCINOMA, RENAL CELL; CELL HYPOXIA; CHROMATIN; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEUROFIBROMATOSIS 2; HISTONE-LYSINE N-METHYLTRANSFERASE; HISTONES; HUMANS; KIDNEY NEOPLASMS; MUTATION; NUCLEAR PROTEINS; OXIDOREDUCTASES, N-DEMETHYLATING; SEQUENCE ANALYSIS, DNA;

EID: 75149188170     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature08672     Document Type: Article

References (27)

1. Eble, J., Epstein, J. & Sesterhann, I. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs (IARC Press, 2004).
2. Rini, B. I., Campbell, S. C. & Escudier, B. Renal cell carcinoma. Lancet 373, 1119-1132 (2009).
3. van Haaften, G. et al. Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. Nature Genet. 41, 521-523 (2009).
4. Banks, R. E. et al. Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer. Cancer Res. 66, 2000-2011 (2006).
5. 2/2 cancer cells detected in a pilot synthetic lethal screen. Proc. Natl Acad. Sci. USA 105, 16484-16489 (2008).
6. Chi, J. T. et al. Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers. PLoS Med. 3, e47 (2006).
7. Jones, S. et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321, 1801-1806 (2008).
8. Parsons, D. W. et al. An integrated genomic analysis of human glioblastoma multiforme. Science 321, 1807-1812 (2008).
9. Greenman, C. et al. Patterns of somatic mutation in human cancer genomes. Nature 446, 153-158 (2007).
10. Sun, X.-J. et al. Identification and characterization of a novel human histone H3 lysine 36-specific methyltransferase. J. Biol. Chem. 280, 35261-35271 (2005).
11. Iwase, S. et al. The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases. Cell 128, 1077-1088 (2007).
12. Issaeva, I. et al. Knockdown of ALR (MLL2) reveals ALR target genes and leads to alterations in cell adhesion and growth. Mol. Cell. Biol. 27, 1889-1903 (2007).
13. Lee, M. G. et al. Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. Science 318, 447-450 (2007).
14. Ferner, R. E. Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective. Lancet Neurol. 6, 340-351 (2007).
15. Gordan, J. D., Bertout, J. A., Hu, C.-J., Diehl, J. A. & Simon, M. C. HIF-2a promotes hypoxic cell proliferation by enhancing c-Myc transcriptional activity. Cancer Cell 11, 335-347 (2007).
16. Zhang, H. et al. HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. Cancer Cell 11, 407-420 (2007).
17. Mandriota, S. J. et al. HIF activation identifies early lesions in VHL kidneys: Evidence for site-specific tumor suppressor function in the nephron. Cancer Cell 1, 459-468 (2002).
18. McKinnon, P. J. & Caldecott, K. W. DNA strand break repair and human genetic disease. Annu. Rev. Genomics Hum. Genet. 8, 37-55 (2007).
19. Kudlow, B. A., Kennedy, B. K. & Monnat, R. J. Werner and Hutchinson-Gilford progeria syndromes: mechanistic basis of human progeroid diseases. Nature Rev. Mol. Cell Biol. 8, 394-404 (2007).
20. Demuth, I. & Digweed, M. The clinical manifestation of a defective response to DNA double-strand breaks as exemplified by Nijmegen breakage syndrome. Oncogene 26, 7792-7798 (2007).
21. DeMasi, J., Huh, K.-W., Nakatani, Y., Münger, K. & Howley, P. M. Bovine papillomavirus E7 transformation function correlates with cellular p600 protein binding. Proc. Natl Acad. Sci. USA 102, 11486-11491 (2005).
22. Huh, K.-W. et al. Association of the human papillomavirus type 16 E7 oncoprotein with the 600-kDa retinoblastoma protein-associated factor, p600. Proc. Natl Acad. Sci. USA 102, 11492-11497 (2005).
23. Young, A. P. et al. VHL loss actuates a HIF-independent senescence programme mediated by Rb and p400. Nature Cell Biol. 10, 361-369 (2008).
24. Dicks, E. et al. AutoCSA, an algorithm for high throughput DNA sequence variant detection in cancer genomes. Bioinformatics 23, 1689-1691 (2007).
25. Greenman, C., Wooster, R., Futreal, P. A., Stratton, M. R. & Easton, D. F. Statistical analysis of pathogenicity of somatic mutations in cancer. Genetics 173, 2187-2198 (2006).
26. Fuhrman, S. A., Lasky, L. C. & Limas, C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am. J. Surg. Pathol. 6, 655-663 (1982)
27. AJCC Cancer Staging Manual 7th edn. (eds Edge, S. B. et al.) (Springer, 2009).